Current state of angina treatment in the outpatient population and heart rate monitoring survey in Latvia (relity latvia)

dc.contributor.authorBalode, Inga
dc.contributor.authorJēgere, Sanda
dc.contributor.authorMintāle, Iveta
dc.contributor.authorNarbute, Inga
dc.contributor.authorZakke, Ilja
dc.contributor.authorLatkovskis, Gustavs
dc.contributor.authorĒrglis, Andrejs
dc.contributor.institutionRīga Stradiņš University
dc.date.accessioned2021-09-24T08:10:01Z
dc.date.available2021-09-24T08:10:01Z
dc.date.issued2010-01
dc.description.abstractThe aim of the REALITY Latvia survey was to accumulate information about treated stable angina outpatients regarding their characteristics, heart rate (HR), treatment, and quality of life. Thirty cardiologists were involved with 1-15 patients each. In total, data about 300 patients were obtained. Patients were examined and questioned during one visit. A high HR was defined above 70 beats per minute (bpm), in accordance to recent evidence. Mean HR was 70.3 ± 11.3 bpm and 45% of patients had HR above 70 bpm. The opinion of practitioners regarding HR differed. For example, a HR level within the range 70-80 bpm was perceived by cardiologists as “normal”, “borderline high” and “high”. The mean target HR that physicians wanted to achieve was 60.1 ± 4.7 bpm. Beta blockers were used in 91% of cases. The more widely used beta blockers were metoprolol (47%) and bisoprolol (35%) in mean daily doses 69.7 ± 30.1 mg and 5.3 ± 2.0 mg, respectively. REALITY Latvia data suggest that, despite wide use of beta blockers, HR control in stable angina patients is insufficient. This is caused by insufficient understanding of HR as a treatment target by physicians and use of beta blockers in suboptimal dosages.en
dc.description.statusPeer reviewed
dc.format.extent8
dc.format.extent153355
dc.identifier.citationBalode, I, Jēgere, S, Mintāle, I, Narbute, I, Zakke, I, Latkovskis, G & Ērglis, A 2010, 'Current state of angina treatment in the outpatient population and heart rate monitoring survey in Latvia (relity latvia)', Proceedings of the Latvian Academy of Sciences, Section B: Natural, Exact, and Applied Sciences, vol. 64, no. 5-6, pp. 194-201. https://doi.org/10.2478/v10046-011-0004-6
dc.identifier.doi10.2478/v10046-011-0004-6
dc.identifier.issn1407-009X
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/6434
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=84857567870&partnerID=8YFLogxK
dc.language.isoeng
dc.relation.ispartofProceedings of the Latvian Academy of Sciences, Section B: Natural, Exact, and Applied Sciences
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectangina
dc.subjectantianginal treatment
dc.subjectheart rate
dc.subjectoutpatient
dc.subject3.2 Clinical medicine
dc.subject1.1. Scientific article indexed in Web of Science and/or Scopus database
dc.subjectGeneral
dc.titleCurrent state of angina treatment in the outpatient population and heart rate monitoring survey in Latvia (relity latvia)en
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Current_state_of_angina_treatment_in_the_outpatient_population.pdf
Size:
149.76 KB
Format:
Adobe Portable Document Format